Joseph Edelman, Director, 10% Owner at Athira Pharma, Inc. (ATHA), bought 2,472,724 shares at $2.99 ($7.4M) on 2022-06-29, disclosed to the SEC on 2022-07-01.
Open-market purchase of $7.4M ATHA by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.99 | 270,000 | $807K | 10.9% |
| 2 | $2.99 | 1,101,362 | $3.3M | 44.5% |
| 3 | $2.99 | 1,101,362 | $3.3M | 44.5% |
| Total | $2.99 avg | 2,472,724 | $7.4M | 100% |
| Filing → |
| MGTX | BUY | 2024-08-14 | $5.0M | — | Filing → |
| ALDX | BUY | 2024-04-08 | $1.7M | — | Filing → |
| ATHA | BUY | 2023-12-29 | $2.9M | — | Filing → |